Brands: Admelog · Humalog · Humalog Kwikpen · Insulin Lispro
Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Eli Lilly and Company | unknown | 6 | SUPPLYING |
| A-S Medication Solutions | repackager | 5 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 2 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Insulin Lispro Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Endocrinology/Metabolism.
Insulin Lispro Injection — reported in shortage by Eli Lilly and Co.. Therapeutic category: Endocrinology/Metabolism.
Lack of Assurance of Sterility: Malformed crimped collar seal — Recalling firm: Sanofi-Aventis U.S. LLC — Nationwide in the USA
Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature. — Recalling firm: Sanofi-Aventis U.S. LLC — Nationwide
